Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Growblox Sciences Inc (GBLX)

Growblox Sciences Inc (GBLX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.40
Trade GBLX with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0270 +35.19%
on 09/08/21
0.0450 -18.89%
on 09/16/21
-0.0031 (-7.83%)
since 08/24/21
3-Month
0.0270 +35.19%
on 09/08/21
0.0630 -42.06%
on 06/29/21
-0.0227 (-38.34%)
since 06/24/21
52-Week
0.0200 +82.50%
on 10/23/20
0.1325 -72.45%
on 02/16/21
+0.0088 (+31.77%)
since 09/24/20

Most Recent Stories

More News
Gb Sciences Achieves Positive Proof-of-Concept Results for Their Cytokine Release Syndrome Therapies Designed to Suppress COVID-Related Hyperinflammation

Gb Sciences, Inc. (OTCQB: GBLX) received positive proof-of-concept data from a human immune cell model supporting their proprietary cannabinoid-containing complex mixtures (CCCM) designed for the suppression...

GBLX : 0.0365 (+7.99%)
Gb Sciences Presenting COVID-Related Cytokine Release Syndrome Results at H.C. Wainwright's 23rd Annual Global Investment Conference

Gb Sciences, Inc. (OTCQB:GBLX), a leading plant-inspired biopharmaceutical development company, today announced that their President and Chief Science Officer, Dr. Andrea Small-Howard, will deliver their...

GBLX : 0.0365 (+7.99%)
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021

The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor...

ACOG.VN : 1.350 (-3.57%)
GET.CN : 0.285 (+1.79%)
MYID.VN : 0.370 (unch)
OSS.VN : 0.640 (unch)
TBRD.VN : 5.000 (+2.25%)
VMC.VN : 5.870 (-0.17%)
VST.CN : 0.445 (-1.11%)
WTEQ.CN : 0.105 (-4.55%)
XXII : 2.97 (-4.19%)
AYRO : 3.60 (-1.10%)
BCDA : 3.35 (-6.42%)
BLGO : 0.1835 (+0.27%)
BITF : 4.84 (-3.59%)
BAMM.CN : 0.590 (+1.72%)
BMMJ : 0.4662 (+1.17%)
BCTX : 9.19 (+10.99%)
BCTXW : 4.95 (+23.75%)
BTX : 9.48 (-5.58%)
CURR : 0.7480 (+7.36%)
DN.TO : 0.4100 (+2.50%)
DLTNF : 0.3324 (+7.23%)
SOLO : 3.54 (-0.56%)
ELLXF : 0.0720 (-9.55%)
FRSAF : 0.0101 (-15.83%)
FLGC : 6.90 (+33.72%)
GMETF : 0.2216 (-0.94%)
GBLX : 0.0365 (+7.99%)
GOVX : 4.32 (-1.14%)
GTMS.TO : 9.43 (-0.84%)
GBNH : 7.47 (-0.40%)
IFA.TO : 3.30 (unch)
IFABF : 2.5600 (-9.54%)
INND : 0.0088 (-6.38%)
ILAL : 0.7500 (-7.41%)
ISDR : 25.65 (-4.68%)
KSPN : 16.74 (-0.36%)
MYIDF : 0.2876 (+0.49%)
LEAF.TO : 2.91 (+3.19%)
LEMLF : 1.9900 (-10.36%)
LXXGF : 0.3200 (-2.26%)
LTBR : 4.92 (-4.65%)
MDP.TO : 3.01 (-1.95%)
MEDXF : 2.3600 (-0.42%)
OSSIF : 0.5035 (-0.42%)
ORGS : 4.95 (-1.00%)
PTPI : 1.9500 (+4.28%)
PRPH : 5.08 (-1.55%)
MAPPF : 0.3068 (-3.70%)
PYR : 3.99 (-3.16%)
PYR.TO : 5.04 (-3.45%)
LUKEF : 0.2291 (-0.39%)
RCRT : 3.81 (-1.55%)
RCRTW : 1.3000 (-10.34%)
RIII : 0.0440 (+12.82%)
SPVNF : 1.0509 (-0.86%)
STAF : 2.07 (-3.72%)
SPCB : 1.0300 (+1.98%)
TGCB : 0.7500 (unch)
TEKCF : 0.4175 (-12.11%)
TFFP : 8.03 (-0.99%)
THBRF : 3.9500 (+2.60%)
VENZF : 0.0693 (+4.37%)
VEV : 4.67 (+0.43%)
VSQTF : 0.3552 (+0.03%)
VIRI : 5.20 (-4.94%)
VMAR : 6.45 (-0.92%)
VNRX : 3.25 (+1.56%)
WTEQF : 0.0830 (-5.68%)
WPNDF : 1.0000 (-0.99%)
XSF.CN : 0.200 (unch)
XSHLF : 0.1514 (+1.61%)
ZIVO : 5.45 (+57.97%)
Gb Sciences to Present at the SNN Network Summer Virtual Event on Wednesday, August 18th, 2021

LAS VEGAS, NV / ACCESSWIRE / August 10, 2021 / Gb Sciences (OTCQB:GBLX), a plant-based research and biopharmaceutical drug development company, today announced that it will be presenting at the SNN Network...

GBLX : 0.0365 (+7.99%)
GB Sciences Is Developing Plant-Inspired Mixtures for Anxiety, Depression, and Pain From PhAROS, GB Sciences' Proprietary AI-Accelerated Drug Discovery Platform

GB Sciences used PhAROS™, their novel AI-accelerated drug discovery platform, to identify and pre-validate optimized therapeutic mixtures for the treatment of anxiety, depression, and pain from mixtures...

GBLX : 0.0365 (+7.99%)
GB Sciences Using AI Technology in Plant-Based Drug Discovery Research

Biotech innovator GB Sciences has launched a drug discovery platform using AI technology that can identify and predict the efficacy of combinations of novel active ingredients from plants.

GBLX : 0.0365 (+7.99%)
Gary Herman Joins GB Sciences' Subsidiary GbS Global Biopharma as Advisory Director

LAS VEGAS / ACCESSWIRE / June 22, 2021 / (OTCQB:GBLX) announces that long-term investor Gary Herman has joined GbS Global Biopharma, Inc., its wholly owned Canadian subsidiary, as an Advisory Director....

GBLX : 0.0365 (+7.99%)
GB Sciences' Board of Directors Has Passed a Unanimous Written Consent Promoting Dr. Andrea Small-Howard to the Role of President

The UWC also retains John Poss as Chairman and CEO of GB Sciences, Inc.

GBLX : 0.0365 (+7.99%)
GB Sciences Featured & Speaking at the SACHS Associates' 4th Annual Neuroscience Innovation Forum

LAS VEGAS, NV / ACCESSWIRE / April 27, 2021 / (OTCQB:GBLX), a leading phytomedicine research and biopharmaceutical development company, will be featured during the SPOTLIGHT SHOWCASE at the for Business...

GBLX : 0.0365 (+7.99%)
GB Sciences and Purisys Announce Preferred Supplier Relationship to Advance Cannabinoid-Containing Pharmaceuticals

Purisys will supply ultra-high purity cannabinoids for use in GB Sciences' cannabinoid-containing, optimized therapeutic mixtures (OTM).

GBLX : 0.0365 (+7.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.0420
2nd Resistance Point 0.0395
1st Resistance Point 0.0380
Last Price 0.0365
1st Support Level 0.0340
2nd Support Level 0.0315
3rd Support Level 0.0300

See More

52-Week High 0.1325
Fibonacci 61.8% 0.0895
Fibonacci 50% 0.0762
Fibonacci 38.2% 0.0630
Last Price 0.0365
52-Week Low 0.0200

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar